retatrutide case study for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials Full article: Efficacy and safety

3,507 GLP-1RAs reduce liver fat accumulation by activating AMPK, which inhibits fatty acid synthesis enzymes and promotes fatty acid -oxidation, thus diminishing lipid droplet accumulation in hepatocytes

If not, please help us keep the lights on by becoming a paid subscriber today

If you miss a dose of NovoLog before eating, you can take your dose during the meal

Nurses Pocket Guide: Diagnoses, Prioritized Interventions, and Rationales Quick-reference tool includes all you need to identify the correct diagnoses for efficient patient care planning

doi: 10.2337/dc17-0291

GLP-1 Receptor Agonists Various large cardiovascular outcome studies have shown a reduction in cardiovascular endpoints with GLP-1 receptor agonists [69]